EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Integrating coronary CT angiography-derived vulnerable plaque features, the systemic immune-inflammation index, and traditional Chinese medicine syndrome elements for prediction of acute coronary syndrome: an exploratory retrospective cohort study

Xiling Hu, Hong Luo, Qingqing Li, Mengdan Feng, Xinbei Li, Mingtai Chen, Hanqing Lyu

Frontiers in Cardiovascular Medicine · 2026-11-10 · 13

DOI: 10.3389/fcvm.2026.2011803 ↗
AbstractBibliografische Angaben

Abstract

Background Acute coronary syndrome (ACS) arises from disruption of coronary atherosclerotic plaques. We assessed whether integrating coronary CT angiography (CCTA)-defined vulnerable plaque (VP), the systemic immune-inflammation index (SII), and traditional Chinese medicine (TCM) syndrome elements improves prediction of incident ACS. Methods This retrospective cohort study enrolled 266 hospitalized patients with >25% coronary stenosis on CCTA (July 2019-July 2021); patients with ACS at baseline were excluded, and all completed a fixed 3-year follow-up from the index CCTA (index date). VP was defined as ≥2 high-risk CCTA features and SII as platelet × neutrophil/lymphocyte count; eight TCM syndrome elements were diagnosed by standardized criteria. Firth-penalized logistic regression with LASSO selection was evaluated by the area under the curve (AUC), calibration, reclassification indices, and decision curve analysis, with selection-inclusive bootstrap internal validation. Results Twenty-two patients developed ACS. In the five-variable Firth model, VP (odds ratio [OR] 12.84, 95% confidence interval [CI] 3.64–45.28), SII (OR 1.18 per 100 × 10 9 /L, 95% CI 1.04–1.33; nonlinear association, P for nonlinearity < 0.001), and the phlegm-turbidity syndrome element (OR 3.07, 95% CI 1.15–8.22) independently predicted ACS. The final three-variable model (ORs 16.30, 1.15 per 100 × 10 9 /L, and 3.65, respectively) showed the best apparent discrimination (AUC 0.873, 95% CI 0.806–0.940; selection-inclusive optimism-corrected AUC 0.812, 95% CI 0.741–0.871) and calibration (intercept −0.07, slope 1.06; Brier score 0.0630), with sensitivity 81.8% and specificity 77.9%, the widest net-benefit threshold range (1%–49%), and nominally higher integrated discrimination improvement over the binary VP indicator (0.073, 95% CI 0.021–0.122). Among 94 patients with VP, spotty calcification, the napkin-ring sign, and stenosis severity were also associated with ACS; SII showed a dose-response relationship (Cochran-Armitage Z = 3.075, P = 0.002); and coexisting blood stasis plus phlegm turbidity marked a subgroup with 56.2% ACS incidence (9/16; exploratory) versus 17.5% (7/40) and 13.6% (3/22) for either element alone. Conclusions An exploratory multimodal model combining CCTA-defined vulnerable plaque, SII, and the phlegm-turbidity syndrome element nominally improved ACS risk prediction over a binary VP indicator. Given the few events and single-center retrospective design, these hypothesis-generating findings require external and prospective validation.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →